Nasdaq Stockholm's listing committee has today notified Ovzon AB (publ) ("Ovzon" or the "Company") the approval of the Company's listing application for the admission trading of the Company's shares on Nasdaq Stockholm (main market). The approval is conditional upon the fulfilment of customary conditions, among others that a prospectus is approved and registered by the Swedish Financial Supervisory Authority ("SFSA"). The trading of the Company's shares on Nasdaq Stockholm is expected to commence on Tuesday April 21, 2020, and the last day of trading on Nasdaq First North Premier Growth Market is expected to be Monday 19 April.
The Company's Board of Directors considers that the listing of the Company's shares on Nasdaq Stockholm is a natural step in the Company's development. The listing is expected to create better conditions for further institutional ownership, increased knowledge of, and transparency of, the Company and the share from analysts and the media, and generally increased interest in the Company, the Company as an employer and the Company's operations.
The listing will also make the Company's share more attractive as a means of payment in connection with potential acquisitions and enable investments in the Company's shares from institutional players whose focus is shares that are admitted to trading on a regulated market. It is the Board of Director's assessment that this creates better conditions for executing on the Company's business plan, which in the long run will promote future value creation for the Company's shareholders.
The shares will be traded unchanged with ticker (Ovzon) and ISIN code (SE0010948711). No offer or issue of new shares will be made in connection with the Company's shares being admitted to trading on Nasdaq Stockholm. Shareholders in Ovzon do not need to take any actions in connection with the list transfer.
Ovzon has prepared a prospectus in connection with the admission to trading of the Company's shares on Nasdaq Stockholm. The prospectus is expected to be approved by the SFSA and published on Ovzon's website, www.ovzon.com, on, or around, Thursday 15 April 2021.
Baker McKenzie is the Company's legal adviser in connection with the admission to trading of the Company's shares on Nasdaq Stockholm.
FNCA Sweden AB, +46(0)8-528 00 399,
For further information please contact;
Magnus René, CEO
+1 781 266 6957
Johan Brandt, CFO
+46 703 69 33 00